Fusion Genomics Corporation



Discovery 1 1450, SFU, 8888 University Drive
Burnaby BC
V5A 1S6

Member Sector: Medical Devices

Fusion Genomics is a molecular diagnostic company that is introducing test kits with companion analysis software that offer superior clinical genotyping information, faster turn-around-times and ease of use for hospitals and clinical laboratories. Fusion is the first of two companies in the world to bring a validated Next Generation Sequencing (NGS) genotyping assay complete with highly secure cloud based analytical service for childhood cancers (ChildSeq-RNA SRCT) into the clinic. This test was validated in the renowned medical testing facility at the Texas Children Hospital, Baylor College of Medicine.

FG is completing development of kits for facilitating absolute diagnosis of pediatric and adult blood cancers. In addition, FG has partnered with both the BC Centre for Disease Control (“BCCDC”) and the Royal Tropical Institute (Dutch: Koninklijk Instituut voor de Tropen; KIT) a World Health Organization reference diagnostic laboratory for infectious diseases to design the next generation of assays for the detection of infectious diseases including drug-resistant forms of tuberculosis, influenza, hepatitis and hemorrhagic fevers including Ebola.